NMPA Approval

Metformin Hydrochloride Sustained-release Tablets（Ⅳ）

Approval Number

国药准字H20233457

Company武汉久安药物研究院有限公司

Registration Date

October 13, 2023

Drug Information

Generic Name

盐酸二甲双胍缓释片(Ⅳ)

Dosage Form

片剂

Strength

1.0g

Drug Type

化学药品

Registration Date

October 13, 2023

Company Information

Applicant Company

Company Name武汉久安药物研究院有限公司

Company Address

武汉东湖新技术开发区高新二路388号光谷国际生物医药企业加速器C11栋19层

Manufacturing Company

Company Name广州玻思韬控释药业有限公司

Company Address

广州高新技术产业开发区科学城开源大道11 号C2栋第六层

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

盐酸二甲双胍缓释片(Ⅳ) - NMPA 批准文号 | MedPath